Q: I bought some medical start-ups in private placements around 2004 through 2007, including TMD Titan Medical. I bought into the both the Canadian and the US private placements. TMD has had a number of frustrating round-trips. Yesterday December 5, TMD stock saw considerable action both sides of border: opened yesterday at 0.90 Canadian , went up 40% to 1.25 closing the day at C$1.15 on high volume. Collapsed this morning. I see no news to explain the swing. The company sent shareholders anote about a strategic review. Perhaps a takeover is in the wings? Do you have any news on TMD? Would you hold or sell? (Tax loss not useable).
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
WELL Health Technologies Corp. (WELL $4.19)
-
CareRx Corporation (CRRX $3.70)
-
Quipt Home Medical Corp. (QIPT $4.98)
Q: These are all huge losers for me. Is it worth keeping all of them, or lightening up? If so what would you let go?
John
John
Q: Would appreciate your views on Canopy.
Q: Is todays drop on LNTH anything to worry about or a buying opportunity?
Thanks for your service!
Thanks for your service!
Q: With the Horizon announcement that there are 2 (named) possible acquirers (by Jan.23/23), would you wait or, after the recent jump, take the money and run?
Q: Your thoughts and comments please. Seems they are going in the right direction but market showing the opposite. What am I missing? Is it the hurricanes?
Q: 1] Opsens Inc XTSE: OPS $2.23 CAD▲ +0.05 (+2.29%) today
2] OpSens Inc.
Short Description: Treasury Offering of Common Shares
Price: $1.90 CND per share.
Settlement: December 22, 2022.
Are 1 & 2 the same?
What does it do exactly? How do I buy it at $1.90? Is it worth buying?
Thank you.
2] OpSens Inc.
Short Description: Treasury Offering of Common Shares
Price: $1.90 CND per share.
Settlement: December 22, 2022.
Are 1 & 2 the same?
What does it do exactly? How do I buy it at $1.90? Is it worth buying?
Thank you.
Q: Thanks for your useful answer. My info is that while legalization of pot in the US is not on the cards for the moment, a bill called the Safe Banking Act (in the US) is expected to pass in 2023 whose passage will allow institutional participation in the sector, which is something they cannot presently do, and a surge in purchases with significant associated price rises is anticipated as a result. This is some way out in front but the markets anticipate and I wondered how much of a hill Canopy for example had to climb, here or in the US.
Q: Hi there. Can you please comment on Biotech as a sector. Particularly the U.S. Would you say that it has been crashed equally or greater that Software. How do you like it’s potential over the next 12-24 months
Q: Abbott is kind of a sleeper, and I would like to sell for a tax loss. Would you agree with this or is it more of a buy at this price? What equity would be similar to ABT as a replacement?
Thank You!
Albert
Thank You!
Albert
Q: I'm a Loyal Holder of Savaria. Like the Company. Past month stock has risen 17%. Has there been any news of late? And what do you forecast for the Future. Thanks so much. Barry from Montréal
-
AbbVie Inc. (ABBV $206.23)
-
Eli Lilly and Company (LLY $917.50)
-
UnitedHealth Group Incorporated (DE) (UNH $280.44)
-
State Street Health Care Select Sector SPDR ETF (XLV $146.62)
-
WELL Health Technologies Corp. (WELL $4.19)
-
Neighbourly Pharmacy Inc. (NBLY $18.60)
Q: Is there something to replace WELL in the Healthcare sector in Canada or US, ETF inclued?
Q: Good Day All,
You recently answered a question on this company from another subscriber, and mentioned something about the cannabis sector. The way the answer was structured leaves me wondering about this remark as I don't believe CRRX operates in that sector; rather it provides drugs to seniors. Is the review of the fundamentals correct for the company, or are your comments based upon a different company in the cannabis sector? Could you clarify?
You recently answered a question on this company from another subscriber, and mentioned something about the cannabis sector. The way the answer was structured leaves me wondering about this remark as I don't believe CRRX operates in that sector; rather it provides drugs to seniors. Is the review of the fundamentals correct for the company, or are your comments based upon a different company in the cannabis sector? Could you clarify?
Q: VRNA Your opinion of this co. as a new investment?
Q: What do you think of this stock? Will it hold together (sorry, couldn't resist) Thx
Q: I am seriously considering pulling the trigger on this one to realize a substantial loss in my trading account. I also hold a position in my tsfa account and plan on riding this into 2023.
Your thoughts regarding taking the tax loss position at this time.
Thanks
Rick
Your thoughts regarding taking the tax loss position at this time.
Thanks
Rick
Q: Are you concerned with ABBV debt to equity of 4.35? If not why? Thanks.
Q: Time to move on? Bought to target medical equipment at a reasonable valuation. Have full positions in ABBV and MRK and VHT for health care. Bought MDT thinking it would do well when medical procedures came back after coved. It was hit on diabetes and now earnings projections. Loosing patience. It is about the same price as 10 yrs ago. Im a value investor and like the dividend but need some growth. Suggestions.
Q: Good evening, 5i team.
I appreciate having your opinion on these 2 names in my RRSP: Gilead got to 52 week high recently and Medtronic was bought recently. Both have decent dividends and good potential.
Your thought on which one to keep if there is room only for 1. Thank you!
I appreciate having your opinion on these 2 names in my RRSP: Gilead got to 52 week high recently and Medtronic was bought recently. Both have decent dividends and good potential.
Your thought on which one to keep if there is room only for 1. Thank you!
Q: Could I please your breakdown of RX recent earning report. Also, would you recommend Buy, Sell or Hold. Thanks … Cal